Liang et al 1 described a Chinese cohort of patients with cancer during the COVID-19 outbreak.The clinical characteristics and outcomes were relevant to our clinical practice.As a whole, patients with cancer have a higher risk for severe events (39% v 8%; P = .0003),including death.Outcomes are even worse in patients who received active treatment in the first month before infection (75% v 43%; odds ratio, 5.34).These patients also had a faster evolution to deterioration (13 v 43 days; P = .0001).